03:31 AM EDT, 07/08/2026 (MT Newswires) -- Nello Mainolfi, Director, Chief Executive Officer, on July 07, 2026, sold 50,000 shares in Kymera Therapeutics ( KYMR ) for $5,950,000. Following the Form 4 filing with the SEC, Mainolfi has control over a total of 666,568 common shares of the company, with 666,568 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1815442/000119312526297817/xslF345X05/ownership.xml